Who owns Outset Medical, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of OM from SEC Form 13F filings across 92 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 92 institutions disclosed 13.8M shares of Outset Medical, Inc. worth $59.8M — about 74.4% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
92
13F holders
$59.8M
value, 2026 filers
74.4%
of shares outstanding (13.8M sh)
20
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of OM's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 2.7M | $11.8M | 0.0% | 14.7% | 0.0% |
| 2 | BML Capital Management, LLC | 2.5M | $10.9M | 6.2% | 13.5% | +32.5% |
| 3 | AQR CAPITAL MANAGEMENT LLC | 998,961 | $4.3M | 0.0% | 5.4% | +23.6% |
| 4 | PERCEPTIVE ADVISORS LLC | 833,333 | $3.6M | 0.1% | 4.5% | 0.0% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 780,134 | $3.4M | 0.0% | 4.2% | +2.1% |
| 6 | BANK OF AMERICA CORP /DE/ | 665,847 | $2.9M | 0.0% | 3.6% | -29.9% |
| 7 | PFM Health Sciences, LP | 582,122 | $2.5M | 0.2% | 3.1% | -2.1% |
| 8 | Ensign Peak Advisors, Inc | 434,341 | $1.9M | 0.0% | 2.3% | -17.5% |
| 9 | BlackRock, Inc. | 418,211 | $1.8M | 0.0% | 2.2% | -66.9% |
| 10 | Assenagon Asset Management S.A. | 339,438 | $1.5M | 0.0% | 1.8% | -32.7% |
| 11 | Peapod Lane Capital LLCNEW | 331,951 | $1.4M | 1.0% | 1.8% | new |
| 12 | MARSHALL WACE, LLPNEW | 211,993 | $915,809 | 0.0% | 1.1% | new |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 204,652 | $884,538 | 0.0% | 1.1% | -51.4% |
| 14 | Stratos Wealth Partners, LTD. | 200,546 | $866,359 | 0.0% | 1.1% | 0.0% |
| 15 | UBS Group AG | 190,289 | $822,048 | 0.0% | 1% | -24.6% |
| 16 | MORGAN STANLEY | 181,983 | $786,166 | 0.0% | 1% | +7.4% |
| 17 | MILLENNIUM MANAGEMENT LLCNEW | 181,794 | $785,350 | 0.0% | 1% | new |
| 18 | GOLDMAN SACHS GROUP INC | 173,460 | $749,348 | 0.0% | 0.9% | +85.8% |
| 19 | JANE STREET GROUP, LLC | 139,197 | $601,331 | 0.0% | 0.7% | +114.8% |
| 20 | XTX Topco Ltd | 124,690 | $538,661 | 0.0% | 0.7% | -12.5% |
| 21 | Catalio Capital Management, LP | 118,279 | $510,965 | 0.1% | 0.6% | 0.0% |
| 22 | VANGUARD FIDUCIARY TRUST CO | 114,912 | $496,420 | 0.0% | 0.6% | +2.9% |
| 23 | GMT Capital Corp | 98,108 | $423,827 | 0.0% | 0.5% | +131.3% |
| 24 | DIMENSIONAL FUND ADVISORS LP | 90,698 | $391,828 | 0.0% | 0.5% | -20.0% |
| 25 | PURA VIDA INVESTMENTS, LLC | 83,333 | $359,999 | 1.0% | 0.4% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.